Hydroxychloroquine Sulfate Tablet, Film Coated
Product Images NDC 68382-096

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydroxychloroquine Sulfate (NDC 68382-096). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

300b4459 0c7d 4f3e 8360 5a7c10b7192c 01

Chemical structure of hydroxychloroquine sulfate, depicting the molecular arrangement including chloro-substituted quinoline and side chains as part of its chemical composition.*

FDA Label Image

300b4459 0c7d 4f3e 8360 5a7c10b7192c 02

Label for Hydroxychloroquine Sulfate Tablets, USP 200 mg, film-coated oral tablets. The label indicates a package containing 100 tablets, manufactured by Cadila Healthcare Ltd., India, and distributed by Zydus Pharmaceuticals USA Inc. It includes instructions on storage, warnings to keep out of reach of children, and a barcode on the left side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.